Boston Scientific's Sandra Nagale Predicts the Future of Medtech Powered by AI Innovations
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
NORTHAMPTON, MA / ACCESSWIRE / November 7, 2023 / Boston Scientific
Originally published by DeviceTalks
In this episode of Boston Scientific Talks, Sandra Nagale, PhD, Director of Digital Health Platforms and Products, breaks down the transformative role of AI within the medical device industry.
Continue reading here.

View additional multimedia and more ESG storytelling from Boston Scientific on 3blmedia.com.
Contact Info:
Spokesperson: Boston Scientific
Website: https://www.3blmedia.com/profiles/boston-scientific
Email: info@3blmedia.com
SOURCE: Boston Scientific
View source version on accesswire.com:
https://www.accesswire.com/800515/boston-scientifics-sandra-nagale-predicts-the-future-of-medtech-powered-by-ai-innovations